Human rabies vaccine

Phase 1Vaccine

CChangchun BCHT Biotechnology Co.

Human rabies vaccine is one of 58 biologic programs targeting Clinical Trial. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Clinical TrialEnrolling by invitation

VaccineCompleted

Clinical TrialPhase 1

Enrolling by invitation

VaccinePreclinical

Completed

Competition

Competitive Landscape

136 competitors in Clinical Trial

#DrugCompanyPhaseTrials

Gemzar

Johnson & Johnson

Phase 3

3 2

Venclexta

AbbVie

Phase 3

2 3

Avelox

Bayer

Phase 3

2 4

Paraplatin

AAvyxa

Phase 3

2 5

Potassium Iodide

MMeda Pharmaceuticals

Phase 3

1 6

Opzelura

DDizal Pharmaceuticals

Phase 3

1 7

Ablysinol

CSL Behring

Phase 3

1 8

Nascobal

GGrupo Espanol de Tumores Neuroendocrinos

Phase 3

1 9

Zelboraf

CConrado Roberto Hoffmann Filho

Phase 2

1 10

FOLFOXIRI

SSun Yat-sen University

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Clinical Trial1 trial

A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell)

Enrolling by invitation·CChangchun BCHT Biotechnology Co.·Phase 1·NCT07338786·80 enrolled

Vaccine1 trial

Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly

Completed·IInstitute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products·N/A·NCT02729168·120 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Human rabies vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Human rabies vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Human rabies vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Changchun BCHT Biotechnology Co. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Phase 1[1]
Company: CChangchun BCHT Biotechnology Co.

Human rabies vaccine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Clinical Trial1 trial

Vaccine1 trial

References

Drug Info

Quick Facts

Related News